IL2 and pancreatic adenocarcinoma: Similar results were observed in patients with adenocarcinoma of the pancreas treated with the anti-folate compound; the authors reported an increase of IFN-γ and IL-2 secretion by natural killer (NK) cells during the treatment, enforcing the role of pemetrexed as a drug that can alter cytokine production in cancer patients [26].